Mammalian target of rapamycin signaling in the podocyte
- PMID: 22388550
- DOI: 10.1097/MNH.0b013e3283520f38
Mammalian target of rapamycin signaling in the podocyte
Abstract
Purpose of review: Mammalian target of rapamycin (mTOR) is an evolutionarily conserved protein kinase. mTOR forms two distinct functional multiprotein kinase complexes that mutually phosphorylate different substrates and regulate a wide array of essential cellular processes including translation, transcription and autophagy. mTOR is active in several types of cancer and plays a role in a variety of other serious human diseases, including diabetes, neurodegenerative disorders and polycystic kidney disease. However, until recently, only very little was known about the function of mTOR in glomerular homeostasis.
Recent findings: Emerging studies highlight the important roles of the mTOR signaling pathway in both maintaining and deregulating glomerular and podocyte function.
Summary: Here we review the current understanding of mTOR signaling in podocyte biology and discuss its implications for the development of glomerular diseases.
Similar articles
-
mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression.Kidney Int. 2011 Mar;79(5):502-11. doi: 10.1038/ki.2010.457. Epub 2010 Nov 17. Kidney Int. 2011. PMID: 21085109 Review.
-
Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.J Cell Physiol. 2014 Jan;229(1):17-26. doi: 10.1002/jcp.24426. J Cell Physiol. 2014. PMID: 23804073 Review.
-
GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility.Am J Physiol Renal Physiol. 2011 May;300(5):F1152-62. doi: 10.1152/ajprenal.00373.2010. Epub 2011 Jan 12. Am J Physiol Renal Physiol. 2011. PMID: 21228102
-
mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes.Am J Physiol Renal Physiol. 2009 Feb;296(2):F418-26. doi: 10.1152/ajprenal.90319.2008. Epub 2008 Nov 19. Am J Physiol Renal Physiol. 2009. PMID: 19019920
-
MTOR regulates autophagic flux in the glomerulus.Autophagy. 2012 Apr;8(4):696-8. doi: 10.4161/auto.19386. Epub 2012 Apr 1. Autophagy. 2012. PMID: 22441016
Cited by
-
The ability of remaining glomerular podocytes to adapt to the loss of their neighbours decreases with age.Cell Tissue Res. 2022 May;388(2):439-451. doi: 10.1007/s00441-022-03611-2. Epub 2022 Mar 15. Cell Tissue Res. 2022. PMID: 35290515 Free PMC article.
-
Autophagy maturation associated with CD38-mediated regulation of lysosome function in mouse glomerular podocytes.J Cell Mol Med. 2013 Dec;17(12):1598-607. doi: 10.1111/jcmm.12173. Epub 2013 Nov 17. J Cell Mol Med. 2013. PMID: 24238063 Free PMC article.
-
The role of autophagy in the pathogenesis of diabetic nephropathy.J Diabetes Res. 2013;2013:193757. doi: 10.1155/2013/193757. Epub 2013 Dec 17. J Diabetes Res. 2013. PMID: 24455746 Free PMC article. Review.
-
Therapeutic Use of mTOR Inhibitors in Renal Diseases: Advances, Drawbacks, and Challenges.Oxid Med Cell Longev. 2018 Oct 29;2018:3693625. doi: 10.1155/2018/3693625. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30510618 Free PMC article. Review.
-
Targeting mTOR Signaling Can Prevent the Progression of FSGS.J Am Soc Nephrol. 2017 Jul;28(7):2144-2157. doi: 10.1681/ASN.2016050519. Epub 2017 Mar 7. J Am Soc Nephrol. 2017. PMID: 28270414 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous